Diagnostic Challenges of LRP4 Antibody Testing in Myasthenia Gravis: A Case Series of Four LRP4 Positive Cases With Uncertain Diagnostic Significance
Case Reports in Neurological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crnm/3092521 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Neurological Medicine, online erschienen am 30.04.2026. Verfasst von Katherine Rosella Kinnard und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ochsner Medical Center, New Orleans, Louisiana, USA, ochsner.org. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myasthenia gravis is an autoimmune disorder characterized by muscle weakness due to impaired neuromuscular transmission. While antibodies against the acetylcholine receptor and muscle‐specific kinase are commonly used for diagnosis, a subset of patients remains seronegative, necessitating alternative biomarkers. Low‐density lipoprotein receptor‐related Protein 4 antibodies have emerged as a potential diagnostic marker in seronegative myasthenia gravis cases. However, misleading positive results have obscured diagnosis and management. This study explores the clinical relevance of low‐density lipoprotein receptor‐related Protein 4 antibodies in myasthenia gravis through four patient case studies. Patients presenting with concern for myasthenia gravis underwent a comprehensive diagnostic evaluation, including antibody testing for acetylcholine receptor, muscle‐specific kinase, and low‐density lipoprotein receptor‐related Protein 4. Volitional single‐fiber electromyography was also performed. All tests were employed per standardized laboratory protocols. All four patients were initially evaluated for suspected myasthenia gravis; however, despite positive low‐density lipoprotein receptor‐related Protein 4 antibody results, comprehensive clinical and electrophysiological evaluation ultimately excluded the diagnosis of myasthenia gravis. These cases underscore the limitations of low‐density lipoprotein receptor‐related Protein 4 antibody testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ochsner Medical Center, New Orleans, Louisiana, USA, ochsner.org.
- Neuromuscular Medicine, Ochsner Medical Center, New Orleans, Louisiana, USA, ochsner.org.
- University of Queensland, Brisbane, Australia, uq.edu.au.
ORCID-Profile: Katherine Rosella Kinnard, Ehtesham Khalid
Zitieren
APA
Kinnard, K. R., & Khalid, E. (2026). Diagnostic Challenges of LRP4 Antibody Testing in Myasthenia Gravis: A Case Series of Four LRP4 Positive Cases With Uncertain Diagnostic Significance. Case Reports in Neurological Medicine, 2026(1). https://doi.org/10.1155/crnm/3092521
Vancouver
Kinnard KR, Khalid E. Diagnostic Challenges of LRP4 Antibody Testing in Myasthenia Gravis: A Case Series of Four LRP4 Positive Cases With Uncertain Diagnostic Significance. Case Reports in Neurological Medicine. 2026;2026(1). doi:10.1155/crnm/3092521
BibTeX
@article{Kinnard2026,
author = {Kinnard, Katherine Rosella and Khalid, Ehtesham},
title = {Diagnostic Challenges of LRP4 Antibody Testing in Myasthenia Gravis: A Case Series of Four LRP4 Positive Cases With Uncertain Diagnostic Significance},
journal = {Case Reports in Neurological Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crnm/3092521}
}
EUVIMED